1887

Abstract

Purpose. Surveillance of the bacterial spectrum and antibiotic-resistance patterns of locally occurring uropathogens is essential to serve as a basis for empirical treatment of urinary tract infections (UTIs), as antibiotic-resistance rates may vary geographically with significant differences between countries and regions, and with time.

Methodology. We retrospectively analysed all urine samples taken in the department of urology in a tertiary care hospital in Hungary from January 2004 to December 2015.

Results/Key findings. The five most commonly occurring bacteria were Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis. Resistance of Escherichia coli to ciprofloxacin increased significantly from 19 to 25 %. Although the resistance of Escherichia coli against cephalosporins showed an increasing trend, it still remained generally low. However, resistance rates of K. pneumoniae to cephalosporins were very high, reaching 60 %, due to the high rate of extended-spectrum-β-lactamase-positive Klebsiella strains. We observed a significant increase in the rate of carbapenem-resistant Pseudomonas aeruginosa.

Conclusion. Fluoroquinolones cannot be recommended for empirical treatment in our region. Cephalosporins can be a good empirical choice for treating Gram-negative UTIs, but should be avoided when multi-drug resistant (MDR) bacteria are suspected. Increases in the rate of carbapenem-resistant Pseudomonas aeruginosa, and in the general rate of MDR bacteria, are both a very alarming trend. We recommend practising prudent antibiotic policy, preferably using antibiotics with the narrowest possible spectrum.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000498
2017-06-16
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/6/788.html?itemId=/content/journal/jmm/10.1099/jmm.0.000498&mimeType=html&fmt=ahah

References

  1. Grabe M, Bjerklund-Johansen TE, Botto H et al. Guidelines on Urological Infections Arnhem:: European Association of Urology; 2015;https://uroweb.org/guidelines/ [accessed 01 December 2015]
    [Google Scholar]
  2. Wagenlehner FM, Naber KG. Treatment of bacterial urinary tract infections: presence and future. Eur Urol 2006;49:235–244 [CrossRef][PubMed]
    [Google Scholar]
  3. Çek M, Tandoğdu Z, Naber K, Tenke P, Wagenlehner F et al. Antibiotic prophylaxis in urology departments, 2005–2010. Eur Urol 2013;63:386–394 [CrossRef][PubMed]
    [Google Scholar]
  4. Wagenlehner FM, Bartoletti R, Cek M, Grabe M, Kahlmeter G et al. Antibiotic stewardship: a call for action by the urologic community. Eur Urol 2013;64:358–360 [CrossRef][PubMed]
    [Google Scholar]
  5. Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV et al. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. data from the PEP and PEAP-studies. Int J Antimicrob Agents 2006;28:S91–S107[CrossRef]
    [Google Scholar]
  6. CLSI Performance Standards for Antimicrobial Susceptibility Testing Wayne, PA: Clinical and Laboratory Standards Institute; 2004;http://clsi.org/ [accessed 14 March 2016]
    [Google Scholar]
  7. EUCAST EUCAST MIC Breakpoint Tables Basel: European Committee on Antimicrobial Susceptibility Testing; 2011;www.eucast.org/ [accessed 12 March 2016]
    [Google Scholar]
  8. Hungarian National Nosocomial Surveillance System (National Epidemiology Centre). 2016;www.oek.hu/oek.web?nid=1070&pid=1 [accessed 02 April 2016]
  9. Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 2012;4:163–169 [CrossRef][PubMed]
    [Google Scholar]
  10. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J Infect 1997;35:283–288 [CrossRef][PubMed]
    [Google Scholar]
  11. Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P et al. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the Global Prevalence of Infections in Urology study. World J Urol 2014;32:791–801 [CrossRef][PubMed]
    [Google Scholar]
  12. Centers for Disease Control and Prevention Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256–260[PubMed]
    [Google Scholar]
  13. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003;9:730–733 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000498
Loading
/content/journal/jmm/10.1099/jmm.0.000498
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error